Thetford Mines, Quebec – December 18, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce the development of a technology platform for its subsidiary AlliancePharma. AlliancePharma is the leader in the placement of pharmacists and technicians with pharmacies in Quebec.

Thetford Mines, Quebec – December 10, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce through its subsidiary AlliancePharma, the development of an education program for pharmacists and technicians about cannabis-based medical products.

Thetford Mines, Quebec – December 12, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce through its subsidiary CanNorth Medic Inc. (“CanNorth Medic”), the development process for the expansion of its plant for cannabis-based medical products. The St-Gabriel de Rimouski plant will increase its surface area to a total of 60,000 square feet for an estimated investment of $5 million.

Thetford Mines, Quebec – November 8, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that the debt settlement previously announced in its press release dated October 31, 2019 has been completed and the Corporation settled indebtedness to a creditor totalling $780,000 in exchange for the issuance of 2,600,000 Class A Shares of KDA (“Common shares”) at a price of $0.30 per Common share (the “Debt Settlement”).

Thetford Mines, Quebec – October 24, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce, following the results of its shareholders’ annual general meeting held yesterday, October 23, 2019 the appointment of Mr. Stan Bharti as a member of the board of directors of the Corporation (the “Board of Directors”).

Thetford Mines, Quebec – August 7, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce that it has signed a letter of intent (“LOI”) with the shareholders of Consultandgrow Inc. (the “Shareholders”) on August 6, 2019 for the purchase of all the shares of Consultandgrow Inc. (“Consultandgrow”).

Thetford Mines, Quebec – July 18, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that the private placement previously announced in its press releases dated December 17, 2018 and March 21, 2019 has been completed with accredited investors totaling 21,500,000 Class A shares (“Common shares”) at a price of $0.15 per Common share for total gross proceeds of $3,225,000 (the “Private Placement”).

Thetford Mines, Quebec – June 26, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce that Dr. Giuseppe D’Aprano is appointed to the Corporation’s management team as Chief Scientific Officer (CSO) as of June 26, 2019.

Thetford Mines, Quebec – February 18, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that the transaction with Strides Pharma Canada inc. (“Strides”) previously announced in its press releases dated December 4, 2018 and February 1st, 2019, according to which Strides acquired 80% of the issued and outstanding shares of its subsidiary Pharmapar Inc. (“Pharmapar”) has been completed.

Thetford Mines, Quebec – February 1st, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce, as previously disclosed in its press release dated December 4, 2018, that it has entered into a share purchase agreement (the “Purchase Agreement”) with Strides Pharmaceuticals Canada Inc. (“Strides”) under which Strides agreed to acquire 80% of the issued and outstanding shares of Pharmapar Inc. (“Pharmapar”), a subsidiary of KDA specializing in the distribution of generic drugs, for four million Canadian dollars (CAN$4,000,000) (the “Sale Price”).